Evidence map›Paper›PMID 33096906›Full record

ReviewInternational journal of molecular sciences2020

Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology.

Sergey Okhota, Ivan Melnikov, Yuliya Avtaeva, Sergey Kozlov, Zufar Gabbasov

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Endothelial heterogeneity shapes shear stress response: a transcriptomic perspective.Research and practice in thrombosis and haemostasis · 2025
    Article
  11. Article
  12. The Phenomenon of Thrombotic Microangiopathy in Cancer Patients.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Impact of Additional Administration of von Willebrand Factor Concentrates to Thrombocyte Transfusion in Perioperative Bleeding in Cardiac Surgery.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sergey OkhotaNational Medical Research Centre of Cardiology of the Ministry of Health of the Russian Federation, 15A, 3-rd Cherepkovskaya Street, 121552 Moscow, Russia.
Ivan MelnikovNational Medical Research Centre of Cardiology of the Ministry of Health of the Russian Federation, 15A, 3-rd Cherepkovskaya Street, 121552 Moscow, Russia.ORCID 0000-0001-5241-3091
Yuliya AvtaevaNational Medical Research Centre of Cardiology of the Ministry of Health of the Russian Federation, 15A, 3-rd Cherepkovskaya Street, 121552 Moscow, Russia.ORCID 0000-0002-3701-9747
Sergey KozlovNational Medical Research Centre of Cardiology of the Ministry of Health of the Russian Federation, 15A, 3-rd Cherepkovskaya Street, 121552 Moscow, Russia.ORCID 0000-0001-8800-1670
Zufar GabbasovNational Medical Research Centre of Cardiology of the Ministry of Health of the Russian Federation, 15A, 3-rd Cherepkovskaya Street, 121552 Moscow, Russia.
National Medical Research Center of Cardiology · RUInstitute of Biomedical Problems · RU

Funding

Russian Science Foundation 16-15-10098-P
6 · The paper itself

Abstract

The von Willebrand factor (vWF) is a plasma protein that mediates platelet adhesion and leukocyte recruitment to vascular injury sites and carries coagulation factor VIII, a building block of the intrinsic pathway of coagulation. The presence of ultra-large multimers of vWF in the bloodstream is associated with spontaneous thrombosis, whereas its deficiency leads to bleeding. In cardiovascular pathology, the progression of the heart valve disease results in vWF deficiency and cryptogenic gastrointestinal bleeding. The association between higher plasma levels of vWF and thrombotic complications of coronary artery disease was described. Of note, it is not the plasma levels that are crucial for vWF hemostatic activity, but vWF activation, triggered by a rise in shear rates. vWF becomes highly reactive with platelets upon unfolding into a stretched conformation, at shear rates above the critical value (more than 5000 s

Indexed as

ADAMTS13 ProteinAnimalsCardiomyopathy, HypertrophicCardiovascular DiseasesHeart Valve DiseasesHumansStress, MechanicalThrombosisvon Willebrand Diseasesvon Willebrand FactorADAMTS13 ProteinADAMTS13 protein, humanvon Willebrand FactorADAMTS-13atherosclerosisatherothrombosiscoronary artery diseaseHeyde’s syndromevon Willebrand factor

Identifiers

PMID33096906
PMCPMC7589699
OpenAlexW3094588364

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.